Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Cytarabine (Cytosafe)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cytarabine 100mg/5ml solution for injection Cytosafe vials
0801030D0BFAAAI
|
Cytarabine (Cytosafe) | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 1g/10ml solution for injection Cytosafe vials
0801030D0BFACAK
|
Cytarabine (Cytosafe) | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 2g/20ml solution for injection Cytosafe vials
0801030D0BFADAL
|
Cytarabine (Cytosafe) | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 500mg/25ml solution for injection Cytosafe vials
0801030D0BFABAM
|
Cytarabine (Cytosafe) | Cytarabine | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.